Skip to main content
Equibles
YARW logo

YARW · Yarrow Bioscience, Inc. · Webcasts, Transcripts & Audio

Track YARW — free

Use YARW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research YARW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.00 +0.43 (+2.20%) At close · Oct 29 Q3 2021 earnings call transcript
Rebalance outlook locked
Market Cap
$52.15M
Shares
2.67M
Volume · Oct 29 228.61K Avg daily vol (3M) 108.87K

Yarrow Bioscience, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Yarrow Bioscience, Inc. (YARW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY25 · Q3
2025-11-06
Yarrow Bioscience, Inc. (YARW) Q3 2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Yarrow Bioscience, Inc. (YARW) Q2 2025 Earnings Call
Revenue
$69,000
▼ 65.2% YoY
Diluted EPS
$-6.73
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2025-07-09
Yarrow Bioscience, Inc. (YARW) July 9, 2025 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q1
2025-05-08
Yarrow Bioscience, Inc. (YARW) Q1 2025 Earnings Call
Revenue
$202,000
▲ 106.1% YoY
Diluted EPS
$-10.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2025-03-20
Yarrow Bioscience, Inc. (YARW) March 20, 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY24 · Q4
2025-03-06
Yarrow Bioscience, Inc. (YARW) Q4 2024 Earnings Call
Revenue
$84,000*
▲ 10.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Yarrow Bioscience, Inc. (YARW) Q3 2024 Earnings Call
Revenue
$121,000
▲ 6.1% YoY
Diluted EPS
$-14.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Yarrow Bioscience, Inc. (YARW) Q2 2024 Earnings Call
Revenue
$198,000
▲ 46.7% YoY
Diluted EPS
$-11.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Yarrow Bioscience, Inc. (YARW) Q1 2024 Earnings Call
Revenue
$98,000
▼ 1% YoY
Diluted EPS
$-7.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Yarrow Bioscience, Inc. (YARW) Q4 2023 Earnings Call
Revenue
$76,000*
▲ 1166.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Yarrow Bioscience, Inc. (YARW) Q3 2023 Earnings Call
Revenue
$114,000
▼ 31.7% YoY
Diluted EPS
$-100.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Yarrow Bioscience, Inc. (YARW) Q2 2023 Earnings Call
Revenue
$135,000
▲ 7.1% YoY
Diluted EPS
$-154.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Yarrow Bioscience, Inc. (YARW) Q1 2023 Earnings Call
Revenue
$99,000
▼ 44.4% YoY
Diluted EPS
$-87.00
▼ 215.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-09
Yarrow Bioscience, Inc. (YARW) Q4 2022 Earnings Call
Revenue
$6,000*
▼ 97.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-10
Yarrow Bioscience, Inc. (YARW) Q3 2022 Earnings Call
Revenue
$167,000
▲ 25.6% YoY
Diluted EPS
$-147.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-12
Yarrow Bioscience, Inc. (YARW) Q2 2022 Earnings Call
Revenue
$126,000
▼ 57.3% YoY
Diluted EPS
$-131.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-17
Yarrow Bioscience, Inc. (YARW) Q1 2022 Earnings Call
Revenue
$178,000
▼ 22.6% YoY
Diluted EPS
$75.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-17
Yarrow Bioscience, Inc. (YARW) Q4 2021 Earnings Call
Revenue
$273,000*
▼ 93.6% YoY
Gross margin
-230.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Yarrow Bioscience, Inc. (YARW) Q3 2021 Earnings Call Transcript
Revenue
$133,000
▼ 95.9% YoY
Diluted EPS
$-369.00
Gross margin
-688.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Yarrow Bioscience, Inc. (YARW) Q2 2021 Earnings Call Transcript
Revenue
$295,000
▼ 97.5% YoY
Diluted EPS
$-351.00
Gross margin
-169.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Yarrow Bioscience, Inc. (YARW) Q1 2021 Earnings Call Transcript
Revenue
$230,000
▼ 86.9% YoY
Diluted EPS
$-378.00
Gross margin
-161.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Yarrow Bioscience, Inc. (YARW) Q3 2020 Earnings Call Transcript
Revenue
$3.27M
Diluted EPS
$-531.00
Gross margin
-718.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Yarrow Bioscience, Inc. (YARW) Q2 2020 Earnings Call Transcript
Revenue
$11.69M
Diluted EPS
$-4347.00
Gross margin
-1430.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Yarrow Bioscience, Inc. (YARW) Q1 2020 Earnings Call Transcript
Revenue
$1.75M
▲ 468.2% YoY
Gross margin
-2279.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 webcasts
Key facts CIK 1566044 CUSIP 92941V407 13F (30d) 3 filings 3 filers Visit website Investor relations